U.S. Antimony's Defense Contract Faces an Execution Test
A $245 million defense contract gives U.S. Antimony strategic value, but investors still need evidence that higher deliveries can produce profitable revenue, cash and sustainable margins.
United States Antimony is trying to turn a $245 million Defense Logistics Agency contract into a durable operating business. That contract, not a one-day share-price move, is the most important fact for investors assessing the company.
The company's first-quarter filing said it completed its first two delivery notices under the DLA agreement. It also reported $6.8 million of revenue, down from $7.0 million a year earlier, and a $11.3 million net loss that included $9.3 million of noncash items. Gross margin fell to 16% from 34%. Those figures show why contract size alone cannot establish earnings power.
The balance sheet gave management more room to execute. United States Antimony raised about $48.6 million of gross proceeds after the first quarter by selling roughly 4.2 million shares at an average price of $11.57. The company put pro forma liquidity at $108.7 million, including cash, Treasury securities and listed investments. That capital can support the Thompson Falls expansion and other projects, but the new shares also diluted existing owners.
The October 19 source report said cumulative DLA orders had reached $57.3 million and that third-quarter deliveries increased. It also described inventory of $21.6 million built to support deliveries. Investors should distinguish those order and inventory figures from recognized revenue and cash collection. The company still has to convert material, production capacity and delivery notices into profitable sales.
The investment case therefore depends on execution at Thompson Falls and on the economics of procuring antimony feedstock. United States Antimony says the DLA contract is sole-source and describes itself as the only fully integrated antimony producer in North America. That positioning may create strategic value, but investors should treat the claim as company-provided until confirmed by contract disclosures and actual shipment data.
Peer price moves offer little help in valuing the business. USA Rare Earth and Critical Metals are developing different assets, at different stages, with different financing needs. Their shares can move with critical-minerals sentiment, but they are not clean operating comparables for United States Antimony.
The next useful evidence will be recognized DLA revenue, cash receipts, gross margin and working-capital use. If deliveries rise while inventory converts to cash, the contract can support a stronger operating profile. If losses and working capital keep growing, the headline contract value will matter less than the cost of fulfilling it.



